Dextromethorphan/Tramadol/Gabapentin

右美沙芬/曲马多/加巴喷丁

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDextromethorphan/Tramadol/Gabapentin

Drug Alias NameDextromethorphan•Tramadol•Gabapentin右美沙芬+曲马多+加巴喷丁右美沙芬和曲马多和加巴喷丁Gabapentin/Tramadol/Dextromethorphan右美沙芬•曲马多•加巴喷丁 +[11]

ClassificationSmall molecules

Mechanisms of ActionMu opioid receptor agonistsVoltage-gated calcium channel alpha2/delta subunit 2 blockersVoltage-gated N-type calcium channel alpha-1B subunit blockers +[4]

TargetsVoltage-gated N-type calcium channel alpha-1B subunitGlutamate [NMDA] receptorMu opioid receptor +[4]

Therapy Area/IndicationsFibromyalgia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Tramadol Hydrochloride Gabapentin Dextromethorphan Hydrobromide

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTrinity Laboratories Inc

China Registration ClassN/A

Develop Information

Active CompaniesTrinity Laboratories Inc

Inactive CompaniesN/A

Active IndicationsFibromyalgia

Inactive IndicationsN/A

Other Information

ATC CodeN/A